CIRRHOSIS, LIVER

This study tests whether adding Babao Dan Capsule (a traditional Chinese medicine) to standard antiviral treatment can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis who are at high risk. About 1,034 adults aged 18-65 with a specific trad…

This study tests whether adding a traditional Chinese herbal formula (Fufang Biejiaruangan) to standard antiviral therapy can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis. About 1,034 high-risk adults (ages 18-65) will be randomly assig…

This study tests whether a low dose of the drug erlotinib can prevent liver cancer in people with advanced liver scarring (fibrosis or cirrhosis). About 60 adults will receive either erlotinib or a placebo for a period of time. The main goal is to see if the drug can change a blo…

This study follows 30 adults with liver cirrhosis who need surgery to stop bleeding from high blood pressure in the liver. Researchers will measure changes in cholesterol and other blood fats before and for 2 years after the operation. The goal is to learn if the surgery improves…

This study looks at 2500 adults with liver scarring (cirrhosis) or high blood pressure in the liver (portal hypertension) to find out how often bleeding happens during planned medical procedures. Standard blood tests often fail to predict bleeding, so researchers will track real-…